Innovative methodology: the developement of a micro-array flow device

Innovative methodology: the developement of a micro-array flow device - TAPAS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47347

Enrollment

300

Registered

2010-04-19

Start date

2010-06-08

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plaatjesaandoeningen Thrombus formation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy men and women aged 18-65

Exclusion criteria

Exclusion criteria: The use of anti-platelet or anti-coagulant drugs

Design outcomes

Primary

Measure	Time frame
The main study parameters are thrombus formation, coagulation and platelet activity in vitro under flow conditions. Based on varying conditions a suitable device for individual patient monitoring will be developed which will be sensitive for normal anti- platelet and anticoagulation medication.	—

Secondary

Measure	Time frame
Non applicable	—

Countries

Netherlands

Outcome results